ESTA241220C25000
- 0.00
- 0.000.00%
Establishment Labs Newsroom
Express News | Elastic Shares Are Trading Higher After Morgan Stanley Initiated Coverage on the Stock With an Overweight Rating and a Price Target of $130
CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva Market Expansion
Why Is Establishment Labs Holdings Inc. (ESTA) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
Establishment Labs(ESTA.US) 10% Shareholder Sells US$4.52 Million in Common Stock
Is It Time To Consider Buying Establishment Labs Holdings Inc. (NASDAQ:ESTA)?
Express News | Establishment Labs Holdings Inc - Amendment Extends Tranche D Term Loans to December 31, 2025
Express News | Establishment Labs Holdings Inc - on Nov 7, Amended Credit Agreement With Oaktree Fund
Establishment Labs | 10-Q: Q3 2024 Earnings Report
Express News | Qatar Investment Authority Reports 6.03% Passive Stake in Establishment Labs Holdings as of Nov 7- SEC Filing
Establishment Labs Announces Participation in Upcoming Investment Conferences
Establishment Labs Holdings (ESTA) Gets a Hold From Citi
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Just Reported And Analysts Have Been Cutting Their Estimates
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript Summary
J.P. Morgan Maintains Establishment Labs(ESTA.US) With Buy Rating, Raises Target Price to $54
TD Cowen Maintains Establishment Labs(ESTA.US) With Buy Rating, Maintains Target Price $75
Establishment Labs Holdings: Strong Market Acceptance and Financial Stability Drive Buy Rating
Establishment Labs Trading Halted, Volatility Trading Pause
BTIG Maintains Establishment Labs(ESTA.US) With Buy Rating, Cuts Target Price to $62
Establishment Labs Holdings Inc (ESTA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
Establishment Labs Reports Narrowed Losses and FDA Approval